211 related articles for article (PubMed ID: 8982294)
1. Transfusion of platelet concentrates--clinical evaluation of two preparations.
Strindberg J; Berlin G
Eur J Haematol; 1996 Oct; 57(4):307-11. PubMed ID: 8982294
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
[TBL] [Abstract][Full Text] [Related]
3. In-vivo evaluation of random donor platelet concentrates from pooled buffy coats.
Klüter H; Dörges L; Maass E; Wagner T; Bartels H; Kirchner H
Ann Hematol; 1996 Aug; 73(2):85-9. PubMed ID: 8774617
[TBL] [Abstract][Full Text] [Related]
4. Determination
Thuku NW; Shikuku K; Mbugua A
Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
[TBL] [Abstract][Full Text] [Related]
5. Transfusion of platelet concentrates from pooled buffy-coats: comparison of bedside vs. prestorage leukofiltration.
Müller-Steinhardt M; Schlenke P; Wagner T; Klüter H
Transfus Med; 2000 Mar; 10(1):59-65. PubMed ID: 10760204
[TBL] [Abstract][Full Text] [Related]
6. Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.
Akkök CA; Brinch L; Lauritzsen GF; Solheim BG; Kjeldsen-Kragh J
Vox Sang; 2007 Jul; 93(1):42-8. PubMed ID: 17547564
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactions.
Anderson NA; Gray S; Copplestone JA; Chan DC; Hamon M; Prentice AG; Johnson SA; Phillips M; van Waeg G; Oakhill A; Abeyasekera S; Pamphilon DH
Transfus Med; 1997 Mar; 7(1):33-9. PubMed ID: 9089983
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
Bertolini F; Rebulla P; Riccardi D; Cortellaro M; Ranzi ML; Sirchia G
Transfusion; 1989 Sep; 29(7):605-9. PubMed ID: 2773027
[TBL] [Abstract][Full Text] [Related]
9. Platelet concentrates in an additive solution prepared from pooled buffy coats. In vivo studies.
Eriksson L; Shanwell A; Gulliksson H; Högman CF; Svensson LA; Kristensen J; Berg B
Vox Sang; 1993; 64(3):133-8. PubMed ID: 8484245
[TBL] [Abstract][Full Text] [Related]
10. Implementation of a new platelet pooling system for platelet concentrates led to a higher corrected count increment after transfusion: a comparative observational study of platelet concentrates before and after implementation.
Dijkstra-Tiekstra MJ; van de Watering LM; Rondeel JM; Slomp J; de Wildt-Eggen J
Transfus Med; 2014 Apr; 24(2):99-104. PubMed ID: 24506143
[TBL] [Abstract][Full Text] [Related]
11. Comparative assessment of prophylactic transfusions of platelet concentrates obtained by the PRP or buffy-coat methods, in patients undergoing allogeneic hematopoietic stem cell transplantation.
Fernández-Muñoz H; Plaza EM; Rivera-Caravaca JM; Candela MJ; Romera M; De Arriba F; Lozano ML; Vicente V; Heras I; Castilla-Llorente C; Rivera J
Hematology; 2018 Oct; 23(9):712-718. PubMed ID: 29582705
[TBL] [Abstract][Full Text] [Related]
12. Adverse reactions to platelet transfusions are reduced by use of platelet concentrates derived from buffy coat.
Oksanen K; Ebeling F; Kekomäki R; Elonen E; Sahlstedt L; Volin L; Myllylä G
Vox Sang; 1994; 67(4):356-61. PubMed ID: 7701806
[TBL] [Abstract][Full Text] [Related]
13. Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods.
Singh RP; Marwaha N; Malhotra P; Dash S
Asian J Transfus Sci; 2009 Jul; 3(2):86-94. PubMed ID: 20808653
[TBL] [Abstract][Full Text] [Related]
14. Relationship of the time of storage and transfusion reactions to platelet concentrates from buffy coats.
Riccardi D; Raspollini E; Rebulla P; Pappalettera M; Marangoni F; Greppi N; Sirchia G
Transfusion; 1997 May; 37(5):528-30. PubMed ID: 9149780
[TBL] [Abstract][Full Text] [Related]
15. Febrile reactions to platelet transfusion: the effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method.
Muylle L; Wouters E; Peetermans ME
Transfusion; 1996 Oct; 36(10):886-90. PubMed ID: 8863775
[TBL] [Abstract][Full Text] [Related]
16. Storage-induced change in platelet transfusion response evaluated by serial transfusions from one donor to one patient.
Tynngård N; Boknäs N; Trinks M; Dreimane A; Berlin G
Transfusion; 2019 Feb; 59(2):723-728. PubMed ID: 30548486
[TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory experience with erythrocyte and platelet preparations from a 0.5CPD Erythro-Sol opti system.
Högman CF; Eriksson L; Wallvik J; Payrat JM
Vox Sang; 1997; 73(4):212-9. PubMed ID: 9407638
[TBL] [Abstract][Full Text] [Related]
18. Platelet concentrates from buffy coats: improved conditions for preparation and evaluation in routine clinical use.
Rebulla P; Bertolini F; Porretti L; Marangoni F; Smacchia C; Marconi M; Riccardi D; Sirelson V; Pappalettera M; Sirchia G
Transfus Sci; 1993 Jan; 14(1):41-6. PubMed ID: 10148312
[TBL] [Abstract][Full Text] [Related]
19. Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial.
van Marwijk Kooy M; van Prooijen HC; Moes M; Bosma-Stants I; Akkerman JW
Blood; 1991 Jan; 77(1):201-5. PubMed ID: 1984797
[TBL] [Abstract][Full Text] [Related]
20. In-process cell counts during preparation of platelet concentrates from buffy coats.
Stampfli R; Schaller M; Schenker T; Frey-Wettstein M; Hauser SP; Nydegger UE
Transfus Sci; 1997 Dec; 18(4):495-503. PubMed ID: 10178672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
